Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
The 2022 plea by an HIV network NGO highlights gaps in procurement and quality of ARV therapy drugs; 16 states yet to file ...
Southern Eye on MSN
ARV probe spotlights ‘sophisticated’ racket at Masvingo hospital
The medical superintendent at Masvingo Provincial Hospital has called on the police to investigate what he described as ...
The Supreme Court will hear a plea on December 3 concerning the supply and quality of anti-retroviral (ARV) drugs for HIV ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
The Supreme Court on Tuesday said it would hear on December 3 a plea that has raised concerns over the supply and quality of anti-retroviral (ARV) therapy drugs for treating HIV patients in the ...
Authorities at Masvingo Provincial Hospital have called for a police investigation into what they suspect is a highly ...
AllAfrica on MSN
Ghana: Local Production of Antiretroviral Drugs to Commence Soon
Atlantic Lifesciences Limited, a sterile pharmaceutical manufacturing company in the Ningo-Prampram district of the Greater Accra Region, has called on the government to support its operations to ...
LUSAKA, Nov. 8 (Xinhua) -- Zambia has approved Lenacapavir, a long-acting injectable antiretroviral (ARV) drug, for the prevention of HIV/AIDS, with the government describing it as a major milestone ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Ernest Amoabeng Ortsin, has revealed that over 1,000 children in Ghana have been infected with HIV/AIDS as a result of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results